Get startedLog in
    Picture of Gensight Biologics SA logo

    SIGHT — Gensight Biologics SA News Story

    0.000.00%
    fr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: GenSight Biologics To Present GS010 (LUMEVOQ) Phase III Trials

    Picture of Gensight Biologics SA logoGensight Biologics SA
    03/03/2020 06:39
    March 3 (Reuters) - GENSIGHT BIOLOGICS SA  SIGHT.PA :
    * GENSIGHT BIOLOGICS ANNOUNCES PRESENTATION OF BILATERAL
VISUAL
RECOVERY FROM GS010 (LUMEVOQ™) PHASE III TRIALS AT THE 46TH
ANNUAL MEETING OF NANOS

Source text for Eikon:  ID:nBw5LKKs4a 
Further company coverage:  SIGHT.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

    Recent news on Gensight Biologics SA

    See all news